NCT03729687View on ClinicalTrials.gov

Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

July 4, 2016

Primary Completion Date

May 30, 2020

Study Completion Date

June 30, 2025

Conditions
Rectal Cancer
Interventions
COMBINATION_PRODUCT

radiotherapy, capecitabine, oxaliplatin

5x5 Gy radiotherapy in 1 week, 4 cycles of CAPOX (capecitabine 1000 mg/m2 x2 d 1-14, oxaliplatin 130 mg/m2 d 1 every third week), surgery

Trial Locations (1)

S-75185

Akademiska sjukhuset, Uppsala

All Listed Sponsors
collaborator

Swedish Cancer Society

OTHER

lead

Uppsala University

OTHER